DCM

DAFNA Capital Management Portfolio holdings

AUM $362M
1-Year Est. Return 0.48%
This Quarter Est. Return
1 Year Est. Return
-0.48%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$353M
AUM Growth
-$40.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
90
New
Increased
Reduced
Closed

Top Buys

1
+$2.91M
2
+$2.58M
3
+$1.81M
4
INGN icon
Inogen
INGN
+$1.78M
5
DNLI icon
Denali Therapeutics
DNLI
+$1.74M

Top Sells

1
+$3.58M
2
+$3.07M
3
+$1.59M
4
ALKS icon
Alkermes
ALKS
+$875K
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$816K

Sector Composition

1 Healthcare 85.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$6.17B
$32.8M 9.3%
404,505
+7,000
STXS icon
2
Stereotaxis
STXS
$240M
$24.1M 6.83%
13,680,554
RVMD icon
3
Revolution Medicines
RVMD
$11.6B
$23.2M 6.58%
656,176
+25,000
MRUS icon
4
Merus
MRUS
$7.22B
$19.4M 5.51%
461,804
+10,000
ATRC icon
5
AtriCure
ATRC
$1.58B
$19.1M 5.42%
592,273
-49,400
CYTK icon
6
Cytokinetics
CYTK
$7.21B
$16M 4.54%
398,100
BPMC
7
DELISTED
Blueprint Medicines
BPMC
$13.5M 3.82%
152,263
+2,500
IBB icon
8
iShares Biotechnology ETF
IBB
$6.22B
$13.1M 3.72%
102,500
AXGN icon
9
Axogen
AXGN
$1.08B
$12.6M 3.57%
680,782
-166,100
ASND icon
10
Ascendis Pharma
ASND
$11.9B
$12.5M 3.55%
80,398
-22,957
IDYA icon
11
IDEAYA Biosciences
IDYA
$2.54B
$9.65M 2.74%
589,330
+90,503
XENE icon
12
Xenon Pharmaceuticals
XENE
$2.88B
$9.18M 2.6%
273,739
KALV icon
13
KalVista Pharmaceuticals
KALV
$538M
$8.68M 2.46%
752,359
-59,319
NBIX icon
14
Neurocrine Biosciences
NBIX
$15.1B
$7.92M 2.25%
71,615
SNDX icon
15
Syndax Pharmaceuticals
SNDX
$1.23B
$6.69M 1.9%
544,502
+2,500
DAWN icon
16
Day One Biopharmaceuticals
DAWN
$983M
$5.8M 1.64%
731,363
TNDM icon
17
Tandem Diabetes Care
TNDM
$1.09B
$5.64M 1.6%
294,208
+71,000
URGN icon
18
UroGen Pharma
URGN
$1.02B
$5.45M 1.54%
492,515
BHVN icon
19
Biohaven
BHVN
$829M
$5.29M 1.5%
220,235
MLYS icon
20
Mineralys Therapeutics
MLYS
$2.85B
$4.91M 1.39%
309,200
+162,700
RCUS icon
21
Arcus Biosciences
RCUS
$2.31B
$4.91M 1.39%
625,126
+370,909
DXCM icon
22
DexCom
DXCM
$21.8B
$4.48M 1.27%
65,552
BCRX icon
23
BioCryst Pharmaceuticals
BCRX
$1.45B
$4.19M 1.19%
558,255
-108,745
EWTX icon
24
Edgewise Therapeutics
EWTX
$1.84B
$4.03M 1.14%
183,140
-4,000
GLPG icon
25
Galapagos
GLPG
$2.05B
$3.27M 0.93%
130,175
1
2 3 4